BCB Glioblastomes - French glioblastoma biobank

Head :
Menei Philippe, CRCINA Inserm U1232 team 17
Bauchet Luc
Figarella-Branger Dominique

Last update : 10/22/2018 | Version : 2 | ID : 73088

print
Print
xml
XML

Export to XML

Please choose the format :

pdf
PDF
xml
CSV (Excel)

Export to CSV

What sections do you want to export ?

Métadonnées
Identification
General Aspects
Scientific investigator(s) (Contact)
Collaborations
Funding
Governance of the database
Additional contact
Type of database
Database objective
Population type
Dates
Size of the database
Data
Procedures
Promotion
Access
Select all | Invert selection | No selection

Which version do you want to export ?

send
Send
General
Identification
Detailed name French glioblastoma biobank
Sign or acronym BCB Glioblastomes
CNIL registration number, number and date of CPP agreement, AFSSAPS (French Health Products Safety Agency) authorisation CNIL02/2013 (1476342v2) ; CPP 23/12/2011-26/02/2013
General Aspects
Medical area Anatomy - Cytology
Biology
Cancer research
Neurology
Radiology and medical imaging
Pathology (details) Glioblastoma
Health determinants Genetic
Geography
Occupation
Keywords Glioblastoma, malignant tumour, tumour, clinical and biological database, central nervous system, bioresource, biobank
Scientific investigator(s) (Contact)
Name of the director Menei
Surname Philippe
Address Service de Neurochirurgie - CHU Angers - 4 rue Larrey - 49000 Angers
Phone +33 2 41 35 48 22
Email phmenei@chu-angers.fr
Unit CRCINA Inserm U1232 team 17
Organization CHU Angers
Name of the director Bauchet
Surname Luc
Address Servide de Neurochirurgie - CHRU Gui de Chauliac - 80 av Augustin Fliche - 34090 Montpellier
Email l-bauchet@chu-montpellier.fr
Organization CHU Montpellier
Name of the director Figarella-Branger
Surname Dominique
Address AP-HM Timone - Service d'anatomie et cytologie pathologiques et de Neuropathologie - 264 rue Saint-Pierre - 13385 Marseille Cedex 05
Email DominiqueFrance.FIGARELLA@ap-hm.fr
Organization Hôpital Timone Marseille
Collaborations
Participation in projects, networks and consortia Yes
Details French glioblastoma biobank
Funding
Funding status Public
Details INCA, IBISA
Governance of the database
Sponsor(s) or organisation(s) responsible CHU Angers
Organisation status Public
Presence of scientific or steering committees Yes
Labelling and database evaluation NF96-900, ISO9001
Additional contact
Main features
Type of database
Type of database Study databases
Study databases (details) Longitudinal study (except cohorts)
Database recruitment is carried out by an intermediary A selection of health institutions and services
Database recruitment is is made on the basis of: Another treatment or procedure
Database recruitment is carried out as part of an interventional study No
Additional information regarding sample selection. Patients with first surgery for glioblastoma, who have given their consent.
Database objective
Main objective The principal purpose of this project is to, over three years, build a national, representative and well-annotated clinical and biological database (CBD) of at least 1,200 glioblastomas.
Inclusion criteria Patients with first surgery for glioblastoma who have given their consent.
Population type
Age Adulthood (19 to 24 years)
Adulthood (25 to 44 years)
Adulthood (45 to 64 years)
Elderly (65 to 79 years)
Great age (80 years and more)
Population covered Sick population
Pathology C00-C75 - Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue
G93 - Other disorders of brain
Gender Male
Woman
Geography area National
Detail of the geography area 29 sites in France
Data collection
Dates
Date of first collection (YYYY or MM/YYYY) 2013
Size of the database
Size of the database (number of individuals) [1000-10 000[ individuals
Details of the number of individuals 1099
Data
Database activity Current data collection
Type of data collected Clinical data
Paraclinical data
Biological data
Clinical data (detail) Direct physical measures
Details of collected clinical data history, surgery, anatomopathology, mri before surgery, follow up every 6 month and cancer treatments
Paraclinical data (detail) MRI before surgery (images and data)
Biological data (detail) Tumoural and peri-tumoral tissue (paraffin block, cryofragment), Blood (plasma, serum, total blood, buffy coat), hair, initial and recidive surgery, before and after surgery
Presence of a biobank Yes
Contents of biobank Whole blood
Serum
Plasma
Tissues
Cell lines
DNA
Others
Details of biobank content Tissue fragment, blood, hair
Health parameters studied Health event/morbidity
Health event/mortality
Procedures
Data collection method anonymous ennov clinical database for clinical data (Clinsight) and biological resources stored in certified Biological Resources Centers
Classifications used ADICAP, CIM10, OMS
Quality procedure(s) used data-management team certified ISO9001, resources stored in certified Biological resources centers NF96-900
Participant monitoring Yes
Monitoring procedures Monitoring by contact with the referring doctor
Details on monitoring of participants Follow-up every 6 month until death
Followed pathology C00-C75 - Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue
Links to administrative sources No
Promotion and access
Promotion
Link to the document https://www.ncbi.nlm.nih.gov/pubmed/24739367
Link to the document https://www.ncbi.nlm.nih.gov/pubmed/29454008
Access
Presence of document that lists variables and coding procedures Yes
Terms of data access (charter for data provision, format of data, availability delay) Contact the scientist in charge
Access to aggregated data Access on specific project only
Access to individual data Access on specific project only

Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05